Anxiety Management in Patients with Hypertension, Hyperlipidemia, and Type 2 Diabetes

Rationale for Benzodiazepine Selection

The American College of Cardiology and other guideline societies recommend lorazepam 0.25-0.5mg orally as needed for anxiety in patients with multiple comorbidities, with a maximum dose of 2mg in 24 hours 1
Lorazepam has a short half-life, lacks active metabolites, and has predictable pharmacokinetics, making it safer in complex medical patients 1
The International Society of Hypertension guidelines recommend RAS-inhibitors and diuretics as preferred antihypertensive agents when treating psychiatric conditions, noting fewer pharmacological interactions 2, 3

Start with the lowest effective dose (0.25mg lorazepam) in patients with multiple comorbidities to minimize risks of oversedation and falls 1
Monitor for paradoxical agitation, which occurs in approximately 10% of patients - if this develops, discontinue the medication immediately 1
Regular evaluation is essential - benzodiazepines can lead to tolerance, addiction, depression, and cognitive impairment with prolonged use 1

The combination of benzodiazepines with opioids significantly increases risk of fatal respiratory depression - avoid concomitant use unless absolutely necessary 4
When combining with antihypertensive medications, RAS-inhibitors (ACE inhibitors, ARBs) and diuretics have fewer interactions compared to other classes 2, 3, 5, 6

SSRIs, particularly sertraline, should be the foundation of treatment for anxiety and depression in this patient population 5, 6
Sertraline has superior cardiovascular safety, lower risk of QTc prolongation, and is effective for both depression and generalized anxiety disorder 5, 6
Use lorazepam 0.25-0.5mg orally PRN for breakthrough anxiety after optimizing SSRI therapy 1

Patients with hypertension and psychiatric disorders have increased cardiovascular risk - depression has been associated with cardiovascular morbidity and mortality 2, 3
The presence of psychiatric disease should increase cardiovascular risk stratification by one step 2, 3
Use caution with calcium channel blockers and alpha-1 blockers when prescribing SSRIs due to potential orthostatic hypotension 2, 3, 5, 6
Screen for anxiety symptoms related to diabetes complications, medication adherence, and hypoglycemia fears 6